RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population

Bin Zhu(Capital Medical University), Jizong Zhao(Capital Medical University), Mingfen Wu(Capital Medical University), Yan Zhang(Shenzhen Children's Hospital), Xixi Li(Chinese Research Academy of Environmental Sciences), Zhigang Zhao(Capital University), Dong Zhang(Beijing Hospital), Xueke Zhen(China-Japan Friendship Hospital), Xingju Liu(Capital Medical University)
Annals of Translational Medicine
July 1, 2020
10.21037/atm-20-1040
Cited by 13

Related Papers

Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial
|The Lancet|2024|142
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
|Journal of Clinical Investigation|2013|107
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105
Expression of Concern: Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor‐suppressive miR‐124
|FEBS Letters|2013|90